Home » Topics » Regulatory

Regulatory
RSS

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...